193 related articles for article (PubMed ID: 28388957)
1. HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer.
Wang Y; Sun J; Li N; Che S; Jin T; Liu S; Lin Z
J Ovarian Res; 2017 Apr; 10(1):26. PubMed ID: 28388957
[TBL] [Abstract][Full Text] [Related]
2. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
[TBL] [Abstract][Full Text] [Related]
3. HBXIP expression predicts patient prognosis in breast cancer.
Cheng D; Liang B; Li Y
Med Oncol; 2014 Oct; 31(10):210. PubMed ID: 25178941
[TBL] [Abstract][Full Text] [Related]
4. HBXIP over expression as an independent biomarker for cervical cancer.
Li N; Wang Y; Che S; Yang Y; Piao J; Liu S; Lin Z
Exp Mol Pathol; 2017 Feb; 102(1):133-137. PubMed ID: 28093193
[TBL] [Abstract][Full Text] [Related]
5. [HBXIP expression in gastric adenocarcinoma predicts poor prognosis].
Piao JJ; Li N; Wang YX; Lin ZH; Liu SP
Zhonghua Bing Li Xue Za Zhi; 2017 Feb; 46(2):88-92. PubMed ID: 28173666
[No Abstract] [Full Text] [Related]
6. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Zhou X; Wang X; Duan J; Sun W; Chen Z; Li Q; Ou Z; Jiang G; Ren X; Liu S
Pathol Res Pract; 2019 Feb; 215(2):343-346. PubMed ID: 30583814
[TBL] [Abstract][Full Text] [Related]
7. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
9. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
10. Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
Xia H; Ma L; Li J; Bai H; Wang D
Am J Cancer Res; 2017; 7(11):2190-2198. PubMed ID: 29218243
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
[TBL] [Abstract][Full Text] [Related]
12. The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.
Xu F; Zhu X; Han T; You X; Liu F; Ye L; Zhang X; Wang X; Yao Y
Int J Oncol; 2014 Jul; 45(1):255-63. PubMed ID: 24788380
[TBL] [Abstract][Full Text] [Related]
13. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
[TBL] [Abstract][Full Text] [Related]
14. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
Guo ZY; Jiang LP; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
[TBL] [Abstract][Full Text] [Related]
15. HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
Wang X; Feng Q; Yu H; Zhou X; Shan C; Zhang Q; Liu S
Life Sci; 2020 Mar; 245():117354. PubMed ID: 31987874
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
19. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
Alabdullah ML; Ahmad DA; Moseley P; Madhusudan S; Chan S; Rakha E
J Obstet Gynaecol; 2019 May; 39(4):522-528. PubMed ID: 30712414
[TBL] [Abstract][Full Text] [Related]
20. Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer.
Sun J; Che SL; Piao JJ; Xu M; Chen LY; Lin ZH
Tumour Biol; 2017 Mar; 39(3):1010428317695918. PubMed ID: 28349826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]